Monday, August 24th, 2015
Nex Board


Hollywood’s latest eco-friendly form of transportation isn’t the latest from Tesla or Toyota; rather, its the NexBoard, a two-wheeled, self-balancing scooter that has young actors and musicians gliding in style.  Spotted on a NexBoard Classix, actress Bella Thorne, 17, was seen running errands in Los Angeles.  Rap artist, Wiz Khalifa, even dared to ride his board through LAX over the weekend — only to be arrested by airport police.

Light, portable, and easy to use, the NexBoard can reach between 9-12 miles on a single battery charge, while traveling 6-9 miles per hour.  The high-tech hoverboard comes in three designs, Classix, NexGen, and Off-Road, which are priced between $599-$999, with an exclusive Off-Raod “Art Edition” retailing for $1,199.



Monday, August 24th, 2015

Acne Before and After Photos Patient 2Let’s face it, acne is truly a four-letter word.  It affects people of all demographics, and often results in permanent scarring.  Until recently, there was never truly an immediate fix for deep acne scars.  Treatments, including microdermabrasion and chemical peels, often result in skin discoloration and additional scarring.  Today, the gold standard is fractional laser resurfacing, achieved through either a single treatment C02 laser (entailing significant downtime) or multiple treatments with a minimally-invasive Erbium laser.  However, like its predecessors, results are not immediately realized.

Recently, Bellafill, a smooth collagen-based dermal filler with polymethylmethacrylate (PMMA) microspheres, was approved by the FDA to treat both nasolabial folds and acne scarring.  Delivering dramatic results in a single office visit (with little-to-no downtime), Bellafill lifts acne indentations while helping the skin recreate its own firmer structure for a smoother appearance.  Celebrity dermatologist, Dr. Ava Shamban, of Beverly Hills, explains, “[It’s] placed below the acne scar depression using a fine needle. The collagen gel provides immediate volume and lift and, over time, is absorbed by the body. The microspheres remain in place and create a matrix that provides structural support to the skin for lasting correction.”


Tuesday, August 18th, 2015

Flibanserin-SproutThe Food and Drug Administration announced on Tuesday its approval of Addyi, a daily, non-hormonal, sex drive-enhancement drug, clinically known as filibanserin.  Designed for premenopausal women affected by hypoactive sexual desire disorder, or HSDD, it is expected to treat nearly 10% of all adult women in the United States who suffer from the condition. HSDD is characterized as “low sexual desire that causes marked distress or interpersonal difficulty and is NOT due to a co-existing medical or psychiatric condition; problems within the relationship, or the effects of a medication or other drug substance.”

Sprout Pharmaceuticals, the drug’s manufacturer, will launch the drug commercially on October 17, 2015, where it will likely retail for between $30-$75 per month (when covered by insurance).  Unlike its male counterpart, Viagra, the drug will take “weeks” to show its efficacy in patients and will be tagged with a “Black Box Warning” against combining it with alcohol and certain antifungals, which have been shown to cause episodes of low blood pressure and fainting.  Addyi acts on the brain chemicals associated with mood an appetite, in the same fashion of an antidepressant.